Pharmacosmos Therapeutics Inc. is the latest life science company to partner with Annexus Health. Healthcare providers can now enroll eligible patients in the Monoferric Patient Solutions® Copay Assistance Program directly within our AssistPoint platform, which also enables them to track the status and spend down of their patients’ Monoferric® (ferric derisomaltose) copay award.
Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric and through exceptional resources to support this treatment. They are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit them at www.monoferric.com to learn more.
AssistPoint is a single enterprise workflow platform that helps provider organizations navigate and manage the patient access journey.
Life science organizations and charitable foundations can integrate their patient support programs with AssistPoint through AP Connect®, creating a two-way, secure information exchange to:
- Improve overall program user experience
- Reduce program communication delays
- Streamline the application, enrollment, and fulfillment process
- Speed up award approval notification for appropriate patients based on eligibility
- Enable immediate access to award balance
About Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
